SymBio PharmaceuticalsSymBio Pharmaceuticals Limited4582東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP
SymBio Pharmaceuticals brought in ¥2.84B in revenue.
It lost about ¥152 for every ¥100 of sales at the operating level.
For every ¥100 SymBio Pharmaceuticals sells, how much goes where, and how much is kept.
Margin funnel (derived from reported values)Gross margin 30.5% → Operating margin -151.6% → Net margin -154.2%
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.